<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref032">
 <label>[32]</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Qin</surname>
   <given-names>H</given-names>
  </string-name>, 
  <string-name>
   <surname>Buckley</surname>
   <given-names>JA</given-names>
  </string-name>, 
  <string-name>
   <surname>Li</surname>
   <given-names>X</given-names>
  </string-name>, 
  <string-name>
   <surname>Liu</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Fox</surname>
   <given-names>TH</given-names>
  </string-name>, 
  <string-name>
   <surname>Meares</surname>
   <given-names>GP</given-names>
  </string-name>, 
  <string-name>
   <surname>Yu</surname>
   <given-names>H</given-names>
  </string-name>, 
  <string-name>
   <surname>Yan</surname>
   <given-names>Z</given-names>
  </string-name>, 
  <string-name>
   <surname>Harms</surname>
   <given-names>AS</given-names>
  </string-name>, 
  <string-name>
   <surname>Li</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Standaert</surname>
   <given-names>DG</given-names>
  </string-name>, 
  <string-name>
   <surname>Benveniste</surname>
   <given-names>EN</given-names>
  </string-name> (
  <year>2016</year>) 
  <article-title>Inhibition of the JAK/STAT pathway protects against 
   <italic>α</italic>-synuclein-induced neuroinflammation and dopaminergic neurodegeneration
  </article-title>. 
  <source>J Neurosci</source>
  <volume>36</volume>, 
  <fpage>5144</fpage>–
  <lpage>5159</lpage>.
  <pub-id pub-id-type="pmid">27147665</pub-id>
 </mixed-citation>
</ref>
